199 related articles for article (PubMed ID: 18599439)
1. Agonist-selective signaling is determined by the receptor location within the membrane domains.
Zheng H; Chu J; Qiu Y; Loh HH; Law PY
Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9421-6. PubMed ID: 18599439
[TBL] [Abstract][Full Text] [Related]
2. GRIN1 regulates micro-opioid receptor activities by tethering the receptor and G protein in the lipid raft.
Ge X; Qiu Y; Loh HH; Law PY
J Biol Chem; 2009 Dec; 284(52):36521-36534. PubMed ID: 19861419
[TBL] [Abstract][Full Text] [Related]
3. Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells.
Huang P; Xu W; Yoon SI; Chen C; Chong PL; Unterwald EM; Liu-Chen LY
Brain Res; 2007 Dec; 1184():46-56. PubMed ID: 17980352
[TBL] [Abstract][Full Text] [Related]
4. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.
Chu J; Zheng H; Zhang Y; Loh HH; Law PY
Cell Signal; 2010 Apr; 22(4):684-96. PubMed ID: 20043990
[TBL] [Abstract][Full Text] [Related]
5. Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation.
Qiu Y; Law PY; Loh HH
J Biol Chem; 2003 Sep; 278(38):36733-9. PubMed ID: 12860981
[TBL] [Abstract][Full Text] [Related]
6. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.
Zhang J; Ferguson SS; Barak LS; Bodduluri SR; Laporte SA; Law PY; Caron MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7157-62. PubMed ID: 9618555
[TBL] [Abstract][Full Text] [Related]
7. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation.
Groer CE; Schmid CL; Jaeger AM; Bohn LM
J Biol Chem; 2011 Sep; 286(36):31731-41. PubMed ID: 21757712
[TBL] [Abstract][Full Text] [Related]
8. Posttranslation modification of G protein-coupled receptor in relationship to biased agonism.
Zheng H; Loh HH; Law PY
Methods Enzymol; 2013; 522():391-408. PubMed ID: 23374194
[TBL] [Abstract][Full Text] [Related]
9. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.
DeWire SM; Yamashita DS; Rominger DH; Liu G; Cowan CL; Graczyk TM; Chen XT; Pitis PM; Gotchev D; Yuan C; Koblish M; Lark MW; Violin JD
J Pharmacol Exp Ther; 2013 Mar; 344(3):708-17. PubMed ID: 23300227
[TBL] [Abstract][Full Text] [Related]
10. Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal.
Zhang L; Zhao H; Qiu Y; Loh HH; Law PY
J Biol Chem; 2009 Jan; 284(4):1990-2000. PubMed ID: 19029294
[TBL] [Abstract][Full Text] [Related]
11. Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization.
Zhao H; Loh HH; Law PY
Mol Pharmacol; 2006 Apr; 69(4):1421-32. PubMed ID: 16415176
[TBL] [Abstract][Full Text] [Related]
12. Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability.
Zheng H; Chu J; Zhang Y; Loh HH; Law PY
J Biol Chem; 2011 Apr; 286(14):12724-33. PubMed ID: 21292762
[TBL] [Abstract][Full Text] [Related]
13. Chronic morphine treatment inhibits opioid receptor desensitization and internalization.
Eisinger DA; Ammer H; Schulz R
J Neurosci; 2002 Dec; 22(23):10192-200. PubMed ID: 12451120
[TBL] [Abstract][Full Text] [Related]
14. RGS9-2 is a negative modulator of mu-opioid receptor function.
Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
[TBL] [Abstract][Full Text] [Related]
15. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activation.
Zheng H; Loh HH; Law PY
Mol Pharmacol; 2008 Jan; 73(1):178-90. PubMed ID: 17947509
[TBL] [Abstract][Full Text] [Related]
17. Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin.
Zhang J; Ferguson SS; Law PY; Barak LS; Caron MG
J Recept Signal Transduct Res; 1999; 19(1-4):301-13. PubMed ID: 10071766
[TBL] [Abstract][Full Text] [Related]
18. Distinct pharmacological properties of morphine metabolites at G(i)-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor.
Frölich N; Dees C; Paetz C; Ren X; Lohse MJ; Nikolaev VO; Zenk MH
Biochem Pharmacol; 2011 May; 81(10):1248-54. PubMed ID: 21396918
[TBL] [Abstract][Full Text] [Related]
19. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
20. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
Miess E; Gondin AB; Yousuf A; Steinborn R; Mösslein N; Yang Y; Göldner M; Ruland JG; Bünemann M; Krasel C; Christie MJ; Halls ML; Schulz S; Canals M
Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
